miR-373 Inhibits Glioma Cell U251 Migration and Invasion by Down-Regulating CD44 and TGFBR2
- 8 February 2016
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 36 (8) , 1389-1397
Abstract
Glioblastoma multiforme (GBM) is the most malignant glioma, unveiling the underlying mechanisms of its aggressiveness could promote the discovery of potential targets for effective treatment. MicroRNAs (miRNAs) are important participants in both development and disease, its involvement in cancers has long been recognized. In this study, we investigated the role of miRNA-373 (miR-373) in GBM cell line U251, demonstrated that although miR-373 does not affect cell growth of U251, it inhibits migration and invasion of U251. Forced expression of miR-373 down-regulates the expressions CD44 and TGFBR2, while knockdown of CD44 and TGFBR2 presents the similar phenotype as miR-373 overexpression, suggesting that CD44 and TGFBR2 are functional targets of miR-373, down-regulation of CD44 and TGFBR2 by miR-373 are partly responsible for the migration, and invasion suppressive role of miR-373 in U251.Keywords
This publication has 44 references indexed in Scilit:
- MicroRNAs in cancer: from developmental genes in worms to their clinical application in patientsBritish Journal of Cancer, 2015
- Upregulation of miR-107 Inhibits Glioma Angiogenesis and VEGF ExpressionCellular and Molecular Neurobiology, 2015
- MiR-218 Inhibited Growth and Metabolism of Human Glioblastoma Cells by Directly Targeting E2F2Cellular and Molecular Neurobiology, 2015
- Diverse functions of miR-373 in cancerJournal of Translational Medicine, 2015
- miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma CellsCellular and Molecular Neurobiology, 2015
- Micro RNA-373 is Down-regulated in Pancreatic Cancer and Inhibits Cancer Cell InvasionAnnals of Surgical Oncology, 2014
- Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of GliomasBrain Pathology, 2010
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- High TGFβ-Smad Activity Confers Poor Prognosis in Glioma Patients and Promotes Cell Proliferation Depending on the Methylation of the PDGF-B GeneCancer Cell, 2007
- A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell TumorsCell, 2006